Dr. Carlos A Pardo-Villamizar's lab at Johns Hopkins University focuses on understanding neurosarcoidosis, a condition that affects the nervous system and arises from a systemic inflammatory disorder. The research aims to identify specific biomarkers and immune profiles linked to the disease, explore the role of genetic signatures, and uncover potential antigens or pathogens that may trigger the inflammatory response. This work seeks to better characterize patient phenotypes and improve therapeutic strategies for neurosarcoidosis.

Dr. Ciprian M. Crainiceanu's lab at Johns Hopkins University focuses on developing advanced statistical methods to analyze neuroimaging data, particularly for diseases like multiple sclerosis (MS). The lab uses innovative modeling techniques to study changes in brain lesions over time and aims to identify new biomarkers that can improve diagnosis and treatment strategies for neurodegenerative diseases. This research is crucial for enhancing our understanding of how such diseases affect brain structure and function.

Dr. Alyssa Coyne's lab investigates the molecular mechanisms underlying neurodegenerative diseases like Amyotrophic Lateral Sclerosis (ALS) and Frontotemporal Dementia (FTD). The research focuses on how disruptions in the nuclear pore complex affect cellular functions in neurons and contribute to disease progression. By studying induced pluripotent stem cell-derived neurons and human tissues, they aim to uncover potential therapeutic targets to prevent or mitigate neurodegeneration.

Dr. Marc M. Greenberg's lab at Johns Hopkins University focuses on the chemistry of nucleic acids, particularly how they get damaged and the biological consequences of that damage. The lab combines techniques from organic chemistry, biochemistry, and molecular biology to explore the mysteries surrounding DNA damage and devise new chemical tools to investigate cellular processes. This research could provide insights into diseases like cancer and lead to the development of new treatment strategies.

Dr. Philipp Oberdoerffer's lab at Johns Hopkins University focuses on understanding how epigenetic mechanisms influence DNA repair processes, particularly in the context of cancer. The team investigates how specific protein variants, especially a histone called macroH2A1, affect the repair of single-stranded DNA lesions that can lead to mutations and cancer. This research aims to improve our understanding of cancer vulnerabilities and potentially enhance treatment strategies.

Dr. Georg Oeltzschner's lab at Johns Hopkins focuses on improving the accuracy of non-invasive brain measurements using magnetic resonance spectroscopy (MRS). The team develops cutting-edge statistical models to analyze biochemical data from the brain, particularly in the context of cancer research. Their goal is to ensure that these methods can reliably capture the complexity of biological data to aid in diagnosing and monitoring treatment responses in diseases affect the brain.

Dr. Bindu Paul's lab at Johns Hopkins University is studying how hydrogen sulfide, a gas produced in the brain, protects against neurodegeneration, particularly in Alzheimer's disease. The team aims to uncover the specific molecules and pathways that are affected by hydrogen sulfide, which could lead to new therapies for age-related brain diseases. Their research combines molecular biology techniques with behavioral studies in mouse models to explore these protective mechanisms.

Dr. Andrew S. Pekosz's lab studies the measles virus, particularly focusing on how the measles vaccine works and its effects on the immune system. The research involves understanding the differences between the wild type measles virus and the vaccine-strain virus in terms of how they replicate and stimulate immune responses. This work is vital for improving vaccination strategies and understanding the long-term health impacts of measles infection and vaccination.

Dr. Katsuyuki Taguchi's lab focuses on advancing x-ray computed tomography (CT) technology by developing innovative photon counting detectors (PCDs). They are particularly interested in improving real-time brain perfusion imaging for stroke patients, enhancing diagnostic precision and treatment outcomes. By integrating novel detector technologies and algorithms, the lab aims to significantly reduce costs and improve performance in medical imaging.

Dr. Jennifer L. Pluznick's lab at Johns Hopkins University focuses on understanding how the olfactory receptor OLFR558 influences blood pressure differences between men and women. The lab explores sex differences in blood pressure regulation using various models, including knockout mice, and investigates the role of OLFR558 ligands—substances that activate this receptor. This research aims to reveal the underlying mechanisms of hypertension and potentially identify new therapeutic strategies.

Dr. Sangeeta Ray's lab focuses on cancer therapies, particularly using targeted radiopharmaceuticals to improve treatment outcomes for prostate and renal cancers. By studying how glutamine metabolism influences cancer cell survival and response to radiation, the lab aims to develop innovative therapies that could enhance the effectiveness of existing treatments. Their work is crucial in understanding how to overcome resistance to radiation therapy in these prevalent cancers.

Dr. Rajini Rao's lab at Johns Hopkins University focuses on understanding how certain proteins help regulate important cellular processes like pH balance and nutrient absorption. Their research connects genetic variations to diseases such as autism and cancer, as well as exploring how mothers and infants get essential minerals during pregnancy and lactation. By developing innovative methods to study these processes, the lab aims to pave the way for better health outcomes for both mothers and their children.

Dr. Tza-Huei Jeff Wang's lab focuses on developing cutting-edge diagnostic platforms to quickly identify bacterial infections and their antibiotic susceptibilities. By using advanced techniques like single-cell molecular analysis and microfluidics, the lab aims to provide faster and more accurate diagnoses for serious conditions like bacteremia and gonorrhea. This work is crucial for improving patient outcomes and tackling the growing problem of antibiotic resistance.

Douglas N Robinson's lab at Johns Hopkins University investigates how cells respond to mechanical forces through their cytoskeletal structures. By studying how cells sense and adapt to their physical environment, the lab aims to uncover the mechanisms behind cellular processes like division and movement, which are fundamental for development and health. The research leverages unique model organisms, advanced imaging techniques, and innovative computational models to explore these fascinating interactions.

Dr. Mathias Unberath's lab is focused on improving surgical techniques for treating vertebral compression fractures using advanced robotic and imaging technologies. They aim to enhance patient safety and reduce radiation exposure during procedures such as vertebral augmentation. By developing innovative robots and algorithms, the lab is working to make surgical robotics more accessible and effective in clinical settings.

Dr. Steven Salzberg's lab at Johns Hopkins University focuses on developing advanced computational methods to analyze and interpret genomic data. By creating new tools and databases, the lab aims to enhance our understanding of human and other genomes, improving gene discovery and genome annotation processes. This research is essential for addressing genetic diseases and expanding the knowledge of biological diversity.

Dr. Nara Sobreira's lab focuses on studying Ollier disease and Maffucci syndrome, two rare conditions linked to cancer susceptibility. The lab investigates the genetic factors and biological pathways that lead to these diseases, aiming to develop new treatments for patients. By examining the phenotypic features, genetic variants, and their impact on a specific cancer-related pathway, the lab seeks to provide insights that could enhance diagnosis and therapy for these and related cancers.

Dr. Payam Mohassel's research lab focuses on understanding how disruptions in lipid metabolism, particularly involving sphingolipids, contribute to motor neuron diseases like amyotrophic lateral sclerosis (ALS). By using cellular and animal models, the lab investigates the effects of specific genetic mutations on neuronal health and explores potential therapeutic strategies to mitigate these effects. Their work aims to reveal new insights into neurodegeneration and develop targeted treatments for ALS.

Dr. Joseph Stayman's lab focuses on improving the accuracy and standardization of radiomics, which are models that help in diagnosing diseases like interstitial lung disease using medical imaging. By developing a mathematical framework, the lab seeks to reduce errors associated with different imaging protocols and devices, ultimately enhancing the reliability of imaging biomarkers. This research is crucial for leveraging large patient image databases for better disease classification and patient outcomes.

Dr. Rejji Kuruvilla's lab at Johns Hopkins University focuses on the interactions between sympathetic neurons and satellite glial cells, which play crucial roles in the sympathetic nervous system. The lab investigates how these glial cells, often overlooked, help regulate neuronal activity and contribute to overall body physiology. By exploring the development and communication mechanisms of these cell types, the research aims to uncover insights that could lead to new therapies for disorders such as chronic heart failure and hypertension.